Since May 2020, the Georgetown Lombardi Arts and Humanities Program has offered more than 65 online classes, attracting participants from 22 states, 23 countries and six continents. In winter 2022, more than 225 participated in the classes each week, building virtual communities around creativity and artistic expression. Read the full story.

Chiranjeev Dash, MBBS, PhD, MPH, has been named to the newly created George E. Richmond Foundation Professorship. The professorship recognizes the outstanding performance and ability of Dash, the assistant director of health disparities research and associate professor of oncology in the Office of Minority Health and Health Disparities Research. View the full announcement.

Jiong Li, PhD, assistant professor at the Virginia Commonwealth in the Department of Medicinal Chemistry and a GHUCCTS KL2 scholar, presents “Targeting FOSL1-Super-enhancers Eliminates Cancer Stem Cells in Head and Neck Squamous Cell Carcinoma.” Register for this Zoom seminar.

Jennifer Marks, MD, presents “MET Exon 14 Skipping Mutation in Non-Small Cell Lung Cancer (NSCLC) by Specific Mutation, Histology, and Smoking History” and Juntae Kwon, PhD, presents “USP13 Overexpression Drives Lineage Plasticity in Lung Cancer Via Stabilizing MYC Protein.” Join the seminar via Zoom.

Terry J. Watnick, MD, the Joan B. and John H. Sadler, MD Professor of Nephrology, University of Maryland, and Gregory Germino, MD, deputy director, National Institute of Diabetes and Digestive and Kidney Diseases, present “Polycystin 1, the Protein Encoded by the Principal Cause of Polycystic Kidney Disease, Regulates Mitochondrial Metabolism.” Join the Dean’s Seminar in the New Research Building Auditorium and via Zoom.

MedPage Today Capivasertib-Fulvestrant Combo Ups Survival in ER+/HER2- Metastatic Breast Cancer

Cancer Center Support Grant (CCSG) Developmental Funds Awards (one-year award at $10,000-$50,000), funded through Georgetown Lombardi’s CCSG, which is funded by NCI. Developmental funds, are available to all Georgetown Lombardi members with a cancer relevant research focus, including basic, clinical, translational or population sciences, with the exception that investigators who have received developmental funds twice within the last five years will not be eligible for additional funds. Projects must begin no later than Sept. 1, 2022, and be completed by Aug. 31, 2023. View full announcement. All applications are due Monday, June 6, to Sharon Levy (SGL5@georgetown.edu).

The American Cancer Society has announced a new RFA focused on testing innovative solutions to improve cancer screening and early detection. This could entail better implementing existing screening tests, adapting current tests and technologies, or developing new tools. Funds will support at least two Interdisciplinary Team Awards, seven Research Scholar Grants, and two Clinician-Scientist Development Grants. View full details on eligibility, scientific scope, application deadlines and more. Letter of Intent due June 15, submitted via proposalCENTRAL.

Gabrielle’s Angel Foundation funds promising physician scientists who are applying novel and state-of-the-art techniques to address fundamental problems in the genesis and treatment of blood related cancers. Applications for this year’s grants are welcome from two junior faculty members at Georgetown Lombardi – one who is conducting mainstream or conventional research and one who is conducting complementary or integrative research. Projects will be funded for a three-year period at $75,000.00 per year. View grant guidelines and application (view application as a Word doc). Electronic grant submission must be received by Friday, August 26 at grants@gabriellesangels.org; three hard copies of the application must be postmarked by that date as well.

Meetings in italics should be attended by all fellows.

8:00 AM | Monday Morning Oncology Report | Podium A / Microsoft Teams

8:30 AM | Division Weekly Update Meeting | Podium A / Microsoft Teams

9:00 AM | Breast Research Meeting | Podium A / Zoom (dial 646-558-8656; Meeting ID: 528212194)

11:00 AM | GU/Melanoma Research Meeting | Podium A / Zoom (dial 646-558-8656; Meeting ID: 796253566)

12:15 PM | ASCO | Podium A / Zoom (dial 646-558-8656; Meeting ID: 987 3224 3543)

4:00 PM | GU Tumor Board (on 1st/3rd Mondays of the month) | Podium A / Zoom (dial 646-558-8656; Meeting ID: 869742463)

9:00 AM | Hematology Path Conference - Inpatient Heme fellows + Outpatient Heme + BMT fellow | Podium A / Microsoft Teams (CME code: 80737; phone: 202-796-7323)

12:15 PM | ASCO | Podium A / Zoom (dial 646-558-8656; Meeting ID: 987 3224 3543)

4:00 PM | Liver Tumor Board | WebEx (dial 844-302-0362; Meeting number (access code): 711 507 430, password: Mse4mGSA2N5)

5:00 PM | Breast Tumor Board | Podium A / Zoom (dial 646-558-8656; Meeting ID: 93777073374; CME code: 80044)

8:00 AM | Thoracic Tumor Board – Thoracic Fellow | Podium A / Zoom

9:00 AM | Thoracic Research Meeting – Thoracic Fellow | Podium A / Microsoft Teams

12:00 PM | Melanoma Tumor Board | Podium A / Microsoft Teams

12:15 PM | No Lecture | Podium A / Zoom (dial 646-558-8656; Meeting ID: 987 3224 3543)

5:00 PM | GI Tumor Board | Podium A / Microsoft Teams

9:00 AM | Cancer Research Data Meeting | Speakers: Sidharth Jain and Thomas Rohwetter | In-person in W302 NRB and Zoom

9:30 AM | Head and Neck Tumor Board - Thoracic Fellow attendance encouraged as clinic allows | Microsoft Teams

12:15 PM | No Lecture | Podium A / Zoom (dial 646-558-8656; Meeting ID: 987 3224 3543)

12:30 PM | GI Research Meeting | WebEx (dial 844-302-0362, Meeting Number (access code): 712527865, HOST PIN: 5514)

5:00 PM | Lymphoma Tumor Board - Biweekly | Microsoft Teams

7:00 AM | CNS Tumor Board | Zoom (dial 646-558-8656; Meeting ID: 378 807 316)

12:00 PM | Oncology Grand Rounds Lecture Series: None

12:15 PM | No Lecture | Zoom (dial 646-558-8656; Meeting ID: 987 3224 3543)

1:00 PM | Pancreas Tumor Board | Microsoft Teams